La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Parkinson Disease, Secondary (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease, Secondary (diagnostic imaging) < Parkinson Disease, Secondary (drug therapy) < Parkinson Disease, Secondary (enzymology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000121 (2000) P. Krack [France] ; P L Dowsey ; A L Benabid ; N. Acarin ; A. Benazzouz ; G. Künig ; K L Leenders ; J A Obeso ; P. PollakIneffective subthalamic nucleus stimulation in levodopa-resistant postischemic parkinsonism.
000125 (2000) R. Bordet [France] ; S. Ridray ; J C Schwartz ; P. SokoloffInvolvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
000126 (2000) S. Aoyama [France] ; H. Kase ; E. BorrelliRescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist.
000198 (2001) N. Callizot [France] ; J L Guénet ; C. Baillet ; J M Warter ; P. PoindronThe frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
000429 (2004) Christophe Jollivet [France] ; Anne Aubert-Pouessel ; Anne Clavreul ; Marie-Claire Venier-Julienne ; Claudia N. Montero-Menei ; Jean-Pierre Benoit ; Philippe MeneiLong-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease.
000430 (2004) Roberto Coccurello [France] ; Nathalie Breysse ; Marianne AmalricSimultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats.
000570 (2005) Abid Oueslati [France] ; Nathalie Breysse ; Marianne Amalric ; Lydia Kerkerian-Le Goff ; Pascal SalinDysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.
000A14 (2009) Dario Cuomo [France] ; Giuseppina Martella ; Emanuela Barabino ; Paola Platania ; Daniela Vita ; Graziella Madeo ; Chelliah Selvam ; Cyril Goudet ; Nadia Oueslati ; Jean-Philippe Pin ; Francine Acher ; Antonio Pisani ; Corinne Beurrier ; Christophe Melon ; Lydia Kerkerian-Le Goff ; Paolo GubelliniMetabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment.
001670 (2015) Gaynor A. Smith [États-Unis] ; Emily M. Rocha [États-Unis] ; Thomas Rooney [France] ; Pascal Barneoud [France] ; Jesse R. Mclean [États-Unis] ; Jonathan Beagan [États-Unis] ; Teresia Osborn [États-Unis] ; Madeleine Coimbra [France] ; Yongyi Luo [États-Unis] ; Penelope J. Hallett [États-Unis] ; Ole Isacson [États-Unis]A Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C)
001710 (1989) M. Zreika [France] ; J R Fozard ; M W Dudley ; P. Bey ; I A Mcdonald ; M G PalfreymanMDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.
001C27 (1987) M. Ziegler [France] ; V. Fournier ; N. Bathien ; P L Morselli ; P. RondotTherapeutic response to progabide in neuroleptic- and L-dopa-induced dyskinesias.
001C89 (1994) A. Boireau [France] ; J M Miquet ; P. Dubédat ; M. Meunier ; A. DobleRiluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
001D00 (1994) A. Kastner [France] ; M T Herrero ; E C Hirsch ; J. Guillen ; M R Luquin ; F. Javoy-Agid ; J A Obeso ; Yves Agid [France]Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
001D28 (1994) F. Tison [France] ; N. Fouillet ; P. HenryApomorphine increases blood glucose concentrations in Parkinson's disease.
001D43 (1993) J M Senard [France] ; O. Rascol ; A. Rascol ; J L MontastrucLack of yohimbine effect on ambulatory blood pressure recording: a double-blind cross-over trial in parkinsonians with orthostatic hypotension.
001E17 (1996) P. Hantraye [France] ; E. Brouillet ; R. Ferrante ; S. Palfi ; R. Dolan ; R T Matthews ; M F BealInhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons.
001E29 (1996) F. Picard [France] ; A. De Saint-Martin ; E. Salmon ; E. Hirsch ; C. MarescauxPostencephalitic stereotyped involuntary movements responsive to L-Dopa.
001E34 (1996) P. Barnéoud [France] ; M. Mazadier ; J M Miquet ; S. Parmentier ; P. Dubédat ; A. Doble ; A. BoireauNeuroprotective effects of riluzole on a model of Parkinson's disease in the rat.
001E42 (1997) M. Vila [France] ; R. Levy ; M T Herrero ; M. Ruberg ; B. Faucheux ; J A Obeso ; Yves Agid [France] ; E C HirschConsequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
001E49 (1997) P. Limousin [France] ; B. Memin ; P. PollakTreatment of dystonia occurring in parkinsonian syndromes by botulinum toxin.
001E88 (1997) E. Bezard [France] ; C. Imbert ; X. Deloire ; B. Bioulac ; C E GrossA chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease, Secondary (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease, Secondary (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease, Secondary (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024